Synspira, Inc.   Report issue

For profit Phase 1
Founded: Boston MA United States (2017)

Organization Overview

First Clinical Trial
2017
NCT03309358
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Alternative names

Synspira, Inc.